Significant predictors of preference for inhaled versus injectable insulin in patients with type 2 diabetes

被引：0
|
作者：
Hayes, R. P. [1 ]
Stump, T. E. [1 ]
Muchmore, D. B. [1 ]
Schmitkel, J. [1 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0974
引用
收藏
页码：S402 / S402
页数：1
相关论文
共 50 条
  • [21] Inhaled insulin leads to a greater potential acceptance of insulin therapy in patients with uncontrolled Type 2 diabetes
    Freemantle, N
    Blonde, L
    Bolinder, B
    Hompesch, M
    Duhot, D
    Eggertsen, R
    Hobbs, EDR
    Martinez, L
    Ross, SA
    Stridde, E
    DIABETOLOGIA, 2004, 47 : A310 - A311
  • [22] Within-subject variability of inhaled insulin (Exubera®) versus subcutaneous regular insulin in elderly obese patients with type 2 diabetes Mellitus
    Henry, R
    Mudaliar, S
    Fryburg, D
    Becker, R
    Willavize, S
    Fisher, J
    Fountaine, R
    Sha, S
    DIABETES, 2003, 52 : A105 - A105
  • [23] Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes
    Freemantle, N
    Blonde, L
    Duhot, D
    Hompesch, M
    Eggertsen, R
    Hobbs, FDR
    Martinez, L
    Ross, S
    Bolinder, B
    Stridde, E
    DIABETES CARE, 2005, 28 (02) : 427 - 428
  • [24] Safety and efficacy of preprandial human insulin inhalation powder (HIIP) delivered by the lilly/alkermes inhaled insulin system versus injectable insulin in patients with type 1 diabetes (T1D)
    Garg, S
    Rosenstock, J
    Muchmore, D
    De La Peña, A
    Sun, B
    Silverman, B
    DIABETES, 2005, 54 : A89 - A89
  • [25] Inhaled insulin with or instead of oral medications for type 2 diabetes
    Rosenstock, J
    Zinman, B
    Murphy, LJ
    Clement, SC
    Moore, P
    Bowering, CK
    Hendler, R
    Lan, SP
    Cefalu, WT
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (08) : I28 - I28
  • [26] Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients
    Pan, Chang-Yu
    Sinnassamy, Patrick
    Chung, Kab-Do
    Kim, Kwang-Won
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 111 - 118
  • [27] Inhaled Technosphere Insulin Versus Inhaled Technosphere Placebo in Insulin-Naive Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetes Agents
    Rosenstock, Julio
    Franco, Denise
    Korpachev, Vadym
    Shumel, Brad
    Ma, Yuhui
    Baughman, Robert
    Amin, Nikhil
    McGill, Janet B.
    DIABETES CARE, 2015, 38 (12) : 2274 - 2281
  • [28] Technosphere insulin: An inhaled mealtime insulin for the treatment of type 1 and type 2 diabetes mellitus
    Phung, Olivia J.
    FORMULARY, 2011, 46 (01) : 14 - 17
  • [29] Within-subject variability of inhaled insulin (Exubera®) versus subcutaneous regular insulin in elderly obese patients with Type 2 diabetes mellitus.
    Mudaliar, S
    Henry, RR
    Fryburg, DA
    Becker, RHA
    Willavize, SA
    Fisher, JM
    Fountaine, R
    Sha, S
    DIABETOLOGIA, 2003, 46 : A277 - A278
  • [30] Predictors of insulin sensitivity in Type 2 diabetes mellitus
    Bonora, E
    Targher, G
    Alberiche, M
    Formentini, G
    Calcaterra, F
    Lombardi, S
    Marini, F
    Poli, M
    Zenari, L
    Raffaelli, A
    Perbellini, S
    Zenere, MB
    Saggiani, F
    Bonadonna, RC
    Muggeo, M
    DIABETIC MEDICINE, 2002, 19 (07) : 535 - 542
12345